https://www.selleckchem.com/pr....oducts/MGCD0103(Moce
ctor-α and interferon-β pathways. COPDGene (NCT00608764), DECAMP-1 (NCT01785342), DECAMP-2 (NCT02504697). COPDGene (NCT00608764), DECAMP-1 (NCT01785342), DECAMP-2 (NCT02504697).There has been increasing research momentum to identify new therapeutic agents for the prevention or treatment of preeclampsia, drugs that can affect the underlying disease pathophysiology. Molecular targets of candidate treatments include oxidative stress, antiangiogenic factors, and the angiotensin, nitric oxide, and proinflammatory pathways. The
Like
Comment
Share
